villash.blogg.se - Tumor en el cerebro tiene cura

TUMOR EN EL CEREBRO TIENE CURA SERIES

Spread to other organs : If the leukemia has spread into the fluid around the brain and spinal cord, and the testicles in boys, it is usually classified as high-risk or very high-risk.

Race/ethnicity : African-American and Hispanic children may have a slightly worse prognosis than other ethnicities.

Gender : In general, girls seem to have a slightly better prognosis than boys, though this gap has shrunk in recent years thanks to today’s advanced treatment options.

For example, children diagnosed with pre-B, common, or early pre-B-cell ALL seem to have a more positive prognosis than children with mature B-cell leukemia, although B-cell ALL can also have a more positive prognosis if treated with intensive chemotherapy.

Subtype : There are many subtypes of leukemia, and some tend to be less aggressive and more responsive to treatment than others.

Initial white blood cell count : Very high white blood cell counts at diagnosis is generally considered high risk or very high risk.

Age does not appear to be a prognosis factor in T-cell ALL and AML. Age at diagnosis : For B- cell ALL, children between the ages of 1 and 9 seem to have a more positive prognosis than children under the age of 1 or over the age of 10.These groupings help determine the intensity of treatment and may impact long-term prognosis. Risk group : A cancer can be classified as standard risk, high risk, or very high risk.In general, these prognosis factors are the same for ALL and AML, but they do not seem to play as great a role in either guiding treatment or predicting outcomes for AML. There are several key prognosis factors that oncologists use when dealing with a leukemia diagnosis.

TUMOR EN EL CEREBRO TIENE CURA SERIES

Prognosis factors are a series of measurements that your child’s oncology team may use to estimate the degree of risk posed by the cancer and to determine the most promising treatment plan. Your child’s prognosis and long-term outlook after treatment will be heavily dependent on your child’s diagnosis, response to treatment, and general health. They are only averages compiled from treated cases of childhood leukemia across the country. These numbers do not, however, provide a specific prognosis for any given child. Moreover, the rates can vary greatly depending on subtype and other factors. The five-year survival rate for acute myelogenous leukemia (AML) is lower, at 60-70%. The five-year survival rate for acute lymphoblastic leukemia (ALL) is now 90%. Thanks to advances in treatment methods, the five-year survival rate for childhood leukemia has greatly improved over the past several decades. In general, children who are still cancer-free after five years are considered “cured” of the disease. When we talk about long-term survival for any childhood cancer, including leukemia, it is important to understand that oncologists and cancer researchers look at the five-year survival rate, or how many children remain cancer-free five years after the end of treatment.

Let’s take a closer look at what these numbers really mean for children with leukemia. That progress is certainly worth celebrating, but these statistics don’t tell the whole story. Just 60 years ago, almost no child with leukemia survived more than a few years, but today, thanks to new discoveries and advances in treatment, 90% of children with the most common type of leukemia will survive. Childhood leukemia is often pointed to as childhood cancer research’s success story.